M. tuberculosis molecular variation in CNS infection: Evidence for strain-dependent neurovirulence

Neurology

Volumn 50, Issue 6, 1998, Pages 1827-1832

  Arvanitakis, Z ^a   Long, R L ^a   Hershfield, E S ^a   Manfreda, J ^a   Kabani, A ^a   Kunimoto, D ^b   Power, Christopher ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Department of Medical Microbiology ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BRAIN INFECTION; CANADA; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FEVER; HEADACHE; HUMAN; MALE; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; TUBERCULOMA; TUBERCULOUS MENINGITIS;

EID: 0031747956     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1827     Document Type: Article

References (38)

1. Zuger A, Lowy FD. Tuberculosis of the brain, meninges and spinal cord. In: Rom WN, Garay SM. Tuberculosis. Boston: Little, Brown 1996:541-556.
2. Girgis NI, Sippel JE, Kilpatrick ME, et al. Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg 1993;48:97-107.
3. Falk A. U.S. Veterans administration-armed forces cooperative study on the chemotherapy of tuberculosis, XIII. Tuberculous meningitis in adults, with special reference to survival, neurologic residuals, and work status. Am Rev Respir Dis 1962;91:823-831.
4. Jereb JA, Kelly GD, Dooley SW, et al. Tuberculosis mortality in the United States: final data, 1990. MMWR CDC Surveill Summ 1991;40(3):23-27.
5. Penner C, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med 1995;151: 867-872.
6. McDonough KA, Kress K. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 1995;63:4802-4811.
7. Collins DM, Kawakami RP, de Lilse GW, Pascopella L, Bloom BR, Jacobs WR. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 1995;92:8036-8040.
8. Friedman CR, Quinn GC, Kreiswirth BN, et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium, tuberculosis. J Infect Dis 1997;176:478-484.
9. Traub M, Colchester ACF, Kingsley DPE, Swash M. Tuberculosis of the central nervous system. Q J Med New Series LIII 1984;209:81-100.
10. Witrack BJ, Ellis GT. Intracranial tuberculosis: manifestations on computerized tomography. South Med J 1985;78: 386-392.
11. World Health Organization. Framework for effective tuberculosis control. WHO/TB/94.17. Geneva, 1994.
12. Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tubercle Lung Dis 1994;75:149-152.
13. Streptomycin in Tuberculosis Trials, Medical Research Council. Streptomycin treatment of tuberculosis meningitis. Lancet 1948;1:582-596.
14. Davis LE, Rastogi R, Lambert C, Skipper J. Tuberculous meningitis in the southwest United States: A community-based study. Neurology 1993;43:1775-1778.
15. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-409.
16. Felsenstein J. Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet 1988;22:521-565.
17. StatXact users manual. Cambridge, MA: Cytel Corporation, 1992.
18. Robins J, Breslow N, Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics 1986;42:311-323.
19. Long RL, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E. Antituberculous drug resistance in Manitoba from 1980 to 1989. Can Med Assoc J 1993;148:1489-1495.
20. Watson JDG, Shnier RC, Seale JP. Central nervous system tuberculosis in Australia: a report of 22 patients. Med J Aust 1993;158:408-413.
21. Bahemuka M, Murungi JH. Tuberculosis of the nervous system: a clinical, radiological and pathological study of 39 consecutive patients in Riyadh, Saudi Arabia. J Neurol Sci 1989; 90:67-76.
22. Molavi A, LeFrock JL. Tuberculous meningitis. Med Clin North Am 1985;69:315-331.
23. Home NW. A critical evaluation of corticosteroids in tuberculosis. Adv Tuberc Res 1966;15:1-54.
24. Humphries M. The management of tuberculous meningitis. Thorax 1992;47:577-581.
25. Ogawa SK, Smith MA, Brennessel DJ, Lowy FD. Tuberculous meningitis in an urban medical center. Medicine 1987;66:317-326.
26. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993;17: 987-994.
27. Sirova M, Hovorka O, Riha I, et al. The in vivo antibody response against exogenous antigens is not influenced by the mouse Beg (Nramp 1) gene. Immunol 1997;90:626-631.
28. Khomenko AG, Litvinov VI, Pospelo LE. Tuberculosis in patients with various HLA phenotypes. Tubercle 1990;71:187-92.
29. Al Arrif LI, Goldstein RA, Affronti LF, Janicki BW. HLA-Bw15 and tuberculosis in a North American black population. Am Rev Respir Dis 1979;120:1275-1278.
30. Shroeder M, Oen K, Jacobson MK, Anderson S. HLA antigens in Aboriginal (Canadian Indian) tribes in Manitoba, Canada. Hum Pathol 1996;47:P322. Abstract.
31. Oen K, Shroeder M, Jacobson MK, et al. Juvenile rheumatoid arthritis in a Canadian First Nations (Aboriginal) population: onset subtypes and HLA associations. J Rheumatol 1998 (in press).
32. Schauf V, Ryan S, Scollard D, et al. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand. Tissue Antigens 1985;26:243-247.
33. Ashton FE, Ryan JA, Borczyk A, Caugant DA, Mancino L, Huang D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 1991;29:2489-2493.
34. Robbins JB, McCracken GH, Gotschuch EC, et al. Echerichia coli K, capsular polysaccharide associated with neonatal meningitis. N Engl J Med 1974;290:1216-1220.
35. Kawano H, Rostapshow V, Rosen L, Lai C. Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol 1993;67:6567-6575.
36. Tucker PC, Strauss EG, Kuhn RJ, Strauss JH, Griffin DE. Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol 1993;67:4605-4610.
37. env alters the neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J Virol 1990;64:5241-5249.
38. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and military tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-1158.